Jun 30 2011

Do CLC bio’s workbenches run on Mac OS X 10.7 Lion?

Tag: Development, Technology, UpdatesGoerlitz @ 15:37

Yes, of course!

System requirements for all workbenches from CLC bio

  • Mac OS X 10.4 or later. PowerPC G4, G5 or Intel CPU required
  • Windows 2000, Windows XP, Windows Vista, or Windows 7
  • Linux: Redhat or SuSE
  • 512 MB RAM required
  • 2 GB RAM recommended
  • 1024 x 768 display recommended
  • 32 and 64 bit platforms supported

Apr 07 2011

1000th developer visits our HQ in Denmark

Tag: Development, Misc.Goerlitz @ 10:26

Not all our customers are aware of our CLC Developer Kit - a free and open API to customize and create your own features and algorithms that plug right in to our line of workbenches or on our server. However, there is a lot of programmers, bioinformaticians, and biologists with coding expertise that use our API to create their own plugins. And just recently we passed an impressive number of 1000 registered developers on our developer forum: http://www.clcdeveloper.com

We wanted to celebrate that, so we contacted the 1000th developer who registered - Raimundas Ražanskas, PhD, from the Institute of Biotechnology at the Vilnius University in Lithuania - and invited him for a trip to our headquarters in Denmark, all expenses paid! In Aarhus, he got to meet our Director of Enterprise Solutions & Worldwide Developer Relations, Mikael Flensborg, who is the chief architect behind our API.

Raimundas & Mikael

Raimundas Ražanskas states:

First of all, I’m not a bioinformatician but a molecular biologist - but I do some small software and scripts now and then, and plan to do more coding and data analysis in the future, as the Vilnius University is planning to acquire a next generation sequencer. My idea is to add some specific features to CLC bio’s workbench, which is why I registered on clcdeveloper.com

Mikael Flensborg, continues:

I have visited a lot of institutions everywhere in the world and done workshops on our API, and it’s really positive to see the interest for developing customized plugins. As a company we know we can’t cover every feature and algorithm that all the scientists in the world want to do, so in that respect we really want to encourage researchers to do this on their own - and with some coding experience it’s relatively straightforward. For commercial software companies, using our API is also an excellent opportunity to reach a wide audience of CLC bio software installations - like for example Omixon have done.

Raimundas Ražanskas rounds off by stating:

Visting CLC bio is a very good experience and the company has many young and motivated specialists, and obviously they make very good software. I like it here in Aarhus!


Nov 04 2009

New benchmarks of our upcoming de novo assembler

Tag: Development, Technology, UpdatesGoerlitz @ 09:27

We have had our upcoming de novo assembly algorithm in internal Alpha for some time now, and have just released an updated technical note with benchmarks from the Alpha 2 version, which is the version we’re currently running.

Impressive benchmarks
These new benchmarks are quite impressive: De novo assembly of a data set with 38 fold coverage of the human genome, completed in only 7 hours on a single computer, while also improving the overall quality!

Click to download the PDF-file with benchmarks on the Alpha 2 version of our upcoming de novo assembly algorithm

Interested in trying this de novo assembler yourself?
Hopefully we can have the beta version out for public testing before Christmas - stay tuned! If you’re interested in more information, you can sign up here and get an invitation, once it’s released: Click to sign up for a beta trial of our de novo assembler


Oct 26 2009

RainDance expand portfolio with Methyl-Seq and Ultra-Deep Resequencing applications

Tag: Development, TechnologyGoerlitz @ 15:01

At last week’s ASHG meeting in Hawaii, our recently announced collaborators, RainDance Technologies, announced that they’re extending the capabilities of their Sequence Enrichment Solution.

Christopher McNary, President and Chief Executive Officer at RainDance Technologies, stated:

Now scientists can apply our Sequence Enrichment Solution to gain better understanding of how disease cells differ from normal cells, enhancing their understanding of the origins and pathways of complex diseases.

Click to read the press release “RainDance Extends Sequence Enrichment Solution Capabilities With Methyl-Seq and Ultra-Deep Resequencing Applications”


Oct 14 2009

Bjarne Knudsen visits Sean Eddy to collaborate on H3

Tag: Development, ProjectsGoerlitz @ 12:44

Last week our Chief Scientific Officer and co-founder of CLC bio, Bjarne Knudsen, visited Sean Eddy of HMMER fame at his lab in Virginia, USA, as part of CLC bio’s commitment to collaborate with Sean Eddy’s lab on the upcoming third - and highly anticipated - version of the HMMER algortihms.

Mr. Eddy has written an entertaining piece in his blog about the current state of HMMER 3 and his encounter with Bjarne Knudsen.

Click to read “Radio silence: Ended” at Eddy’s Cryptogenomicon blog


Next Page »